Training patients for self-administration of a new subcutaneous C1-inhibitor concentrate for hereditary angioedema.

导出 LinkOut

翻译打印收藏纠错

作者： Elyse,Murphy ^[1] ; Christine,Donahue ^[1] ; Laurel,Omert ^[1] ; Stephanie,Persons ^[2] ; Thomas J,Tyma ^[3] ; Joseph,Chiao ^[1] ; William,Lumry ^[4]

作者单位： CSL Behring King of Prussia Pennsylvania. ^[1] Allergy, Asthma, Immunology Medical Care Portland Oregon. ^[2] Asthma, Allergy & Immunology Associates, Ltd. Scottsdale Arizona. ^[3] AARA Research Center Dallas Texas. ^[4]

关键词 C1‐INH(SC)C1‐inhibitor HAEGARDA hereditary angioedema prophylaxis self‐administration subcutaneous

DOI 10.1002/nop2.194

PMID 30534402

发布时间 2023-10-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Nursing open

2019年6卷1期

126-135页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Training patients for self-administration of a new subcutaneous C1-inhibitor concentrate for hereditary angioedema.

Nursing open

相似文献

Nursing open

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Training patients for self-administration of a new subcutaneous C1-inhibitor concentrate for hereditary angioedema.

Nursing open

相似文献

Nursing open

相关期刊

检索历史清除